Primary and secondary conditions of immunodeficiency, as well as immunodeficiency diseases, have specific treatment characteristics. Bone marrow transplantation, autoimmune diseases, secondary antibody deficiency syndrome and primary immunodeficiency syndrome use Bioven in Ukraine. The drug in the form of a solution for infusions has also established itself in therapeutic and prophylactic purposes for viral and bacterial infections. Experts recommend Biovenom treatment from the age of 18.

The preparation Bioven has in the composition of immunoglobulin G (its protein fraction with immunologically active properties), aminoacetic acid and water for injections. Available in the form of a solution of 10, 25 and 50 ml. Introduced by a dropwise method intravenously. The rate of administration of the drug is calculated by a specialist taking into account the disease and the degree of severity of the patient's condition.

Clinically proven benefits of the drug The widely known drug Bioven has in its country undeniable advantages associated with the pharmacological effects on the body:.

has a balanced ratio of subclasses of immunoglobulin G and A;.

antibodies, as the main active component of the drug, are specifically active against viruses and bacteria;.

Bioven is able to influence hepatitis A and B, influenza, chicken pox, herpesvirus, parotitis, measles, rubella, poliomyelitis, whooping cough, pneumococcus, staphylococcus, E. coli;.

strengthens the resistance of the whole organism;.

antibodies to the blood are delivered at high speed and without loss;.

technological processes include the processing of the semi-finished product with a solvent and surfactant, which are removed at the post-production stage by ion-exchange chromatography;.

the effectiveness of the inactivation of model viruses is well studied and described in the instruction.

What is known about the deficiencies of Bioven With caution, it is necessary to administer the drug to people with previously identified severe allergic reactions to the introduction of protein blood preparations. In the presence of diagnosed allergies to immunoglobulins, the drug is prescribed in combination with antihistamine. Consultation of a specialist with systemic immunopathologies is mandatory: nephritis, collagenosis. It is advisable to consult an allergist if there are concerns.

Usually the drug is well tolerated.

Of the adverse events, Bioven immunoglobulin in rare precedents can provoke hyperemia, moderate hyperthermia to 37.5? C (on the 1st day of treatment), an allergy in a particular group of patients with altered reactivity, anaphylactic shock - only in rare cases. Precisely because to avoid any negative phenomena, the drug is injected into the individual infusion system permanently under the control of physicians for at least half an hour after the procedure. Obligatory aseptic conditions and adjusting the temperature of the solution to room comfort temperature.